Skip to main content

GTS SECURITIES LLC

Broker-Dealer

Position in ESPR — Esperion Therapeutics, Inc.

CIK 1452765 NEW YORK, NY

Position in ESPR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
271,769
+100.6% QoQ
Ownership
0.106%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2023
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ESPR Over Time

Shares Held

Position Value (USD)

Derivatives in ESPR

reported options exposure · as of Sep 30, 2024
CallValue
$0
CallShares
10,700
PutValue
$0
PutShares
105,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

GTS SECURITIES LLC holds $347,776 across 3 Drug Manufacturers - Specialty & Generic names. ESPR ranks #3 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 ESPR
Esperion Therapeutics, Inc.
This page
271,769 $0

All Filings in ESPR

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 271,769
2024-09-30 105,500
2024-09-30 10,700
2024-09-30 135,505
2024-06-30 51,600
2024-06-30 107,109
2024-06-30 124,400
2024-03-31 35,200
2024-03-31 15,900
2024-03-31 74,396
2023-12-31 30,700
2023-12-31 47,700
2023-12-31 27,110
2023-09-30 14,127